GENinCode (LON:GENI) Sets New 12-Month Low – Here’s What Happened

GENinCode Plc (LON:GENI) shares reached a new 52-week low during trading on Monday . The company traded as low as GBX 0.90 and last traded at GBX 0.95, with a volume of 19445963 shares changing hands. The stock had previously closed at GBX 1.17.

GENinCode Stock Performance

The firm’s fifty day moving average price is GBX 1.13 and its 200-day moving average price is GBX 1.53. The company has a current ratio of 0.93, a quick ratio of 15.89 and a debt-to-equity ratio of 117.74. The firm has a market cap of £6.78 million, a price-to-earnings ratio of -0.40 and a beta of 0.59.

GENinCode (LON:GENI) last announced its quarterly earnings results on Monday, June 8th. The company reported GBX (2.08) earnings per share for the quarter. The company had revenue of GBX 308 million during the quarter. GENinCode had a negative net margin of 185.47% and a negative return on equity of 409.40%. Analysts expect that GENinCode Plc will post -7.1299999 earnings per share for the current year.

About GENinCode

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.